Viemed Healthcare (VMD) Share-based Compensation (2018 - 2026)
Viemed Healthcare (VMD) posted Share-based Compensation of $2.0 million for Q1 2026, up 139.15% on a QoQ basis from -$5.1 million in Q4 2025, and down 13.63% year-over-year from $2.3 million in Q1 2025.
Viemed Healthcare (VMD) Share-based Compensation (2018 - 2026) Analysis & Trends
Viemed Healthcare's Share-based Compensation history runs 9 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Share-based Compensation fell 13.63% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 81.41% YoY) and the FY2025 annual result came in at $1.7 million, down 72.41% from the prior year.
- Share-based Compensation was $2.0 million for Q1 2026 at Viemed Healthcare, up from -$5.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.3 million in Q4 2023 and bottomed at -$5.1 million in Q4 2025.
- A 5-year average of $1.2 million and a median of $1.3 million in 2022 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 5492.47% in 2025, while the deepest fall reached 6281.82% in 2025.
- Viemed Healthcare's Share-based Compensation stood at $1.3 million in 2022, then surged by 298.94% to $5.3 million in 2023, then fell by 0.65% to $5.2 million in 2024, then sank by 197.66% to -$5.1 million in 2025, then jumped by 139.15% to $2.0 million in 2026.
- Business Quant data shows VMD's Share-based Compensation at $2.0 million in Q1 2026, -$5.1 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | -5.10 Mn |
| Dec 31, 2025 | -5.10 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | -680,000.00 |
| Jun 30, 2025 | -680,000.00 |
| Mar 31, 2025 | 2.31 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Dec 31, 2024 | 5.22 Mn |
| Sep 30, 2024 | 93,000.00 |
| Sep 30, 2024 | 93,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 961,000.00 |
| Mar 31, 2024 | 961,000.00 |
| Dec 31, 2023 | 5.25 Mn |
| Dec 31, 2023 | 5.25 Mn |